Insights - Yesterday, Essa (EPIX) announced another collaboration, this time with Bayer. The two companies will run a combination of Essa’s EPI-7386 with Bayer’s Nubeqa (darolutamide) in patients with … Continue Reading
PremiumResearch - The ASCO 2021 meeting is going to be June 4-8. This morning, ASCO 2021 abstract titles were released. May 19th is when selected abstracts (details other than just … Continue Reading
PremiumInsights - Affimed had their business update call this morning to primarily discuss updates on AFM24 and a few other items. Below are notes. Licensed NK Cells from MD … Continue Reading
PremiumInsights - Affimed(AFMD) hosted a call after market today to discuss cbNK+AFM13 data presented at AACR. KOL from MD Anderson Dr. Katy Rezvani was also on the call. Below … Continue Reading
PremiumInsights - A look at pre-clinical data that Jounce and Essa presented at AACR this past weekend. Jounce (JNCE)Jounce has breached the $10/share level with a weak … Continue Reading
PremiumInsights - Affimed (AFMD) released initial clinical data from the AFM13 + MD Anderson combo study at AACR this morning and it looked great. Ultimately, this data validates AFMD … Continue Reading
PremiumResearch - Novavax (NVAX) has been one of the companies most affected by the March biotech decline. It is now trading under $200/share, near levels where it … Continue Reading
Premium
